IRIDEX Corporation (IRIX): Price and Financial Metrics

IRIDEX Corporation (IRIX)

Today's Latest Price: $1.69 USD

0.01 (-0.59%)

Updated Nov 27 1:00pm

Add IRIX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IRIX Stock Summary

  • With a market capitalization of $23,486,881, Iridex Corp has a greater market value than only 8.44% of US stocks.
  • For IRIX, its debt to operating expenses ratio is greater than that reported by just 17.94% of US equities we're observing.
  • With a price/sales ratio of 0.66, Iridex Corp has a higher such ratio than merely 18.92% of stocks in our set.
  • Stocks that are quantitatively similar to IRIX, based on their financial statements, market capitalization, and price volatility, are ISR, CSPI, TOUR, SPNE, and SNES.
  • IRIX's SEC filings can be seen here. And to visit Iridex Corp's official web site, go to

IRIX Stock Price Chart Interactive Chart >

Price chart for IRIX

IRIX Price/Volume Stats

Current price $1.69 52-week high $4.24
Prev. close $1.70 52-week low $1.22
Day low $1.68 Volume 47,600
Day high $1.73 Avg. volume 42,599
50-day MA $1.86 Dividend yield N/A
200-day MA $2.01 Market Cap 23.49M

IRIDEX Corporation (IRIX) Company Bio

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. The company was founded in 1989 and is based in Mountain View, California.

IRIX Latest News Stream

Event/Time News Detail
Loading, please wait...

IRIX Latest Social Stream

Loading social stream, please wait...

View Full IRIX Social Stream

Latest IRIX News From Around the Web

Below are the latest news stories about Iridex Corp that investors may wish to consider to help them evaluate IRIX as an investment opportunity.

Glaucoma Surgery Devices Market With Top Players likeAbbott Laboratories, Alcon, ASICO, LLC. Carl Zeiss Meditec AG, Glaukos Corporation, Iridex Corporation, Katalyst Surgical Lumenis Ltd. Nidek Co., Ltd., Ziemer Ophthalmic Systems AG

Glaucoma is a small device that is surgically inserted into the eye to increase the outflow of intraocular fluid and lessen high eye pressure. Surgery includes either laser treatment or making a cut in the eye to reduce intraocular stress.

OpenPR | October 1, 2020

IRIDEX's (IRIX) CEO Dave Bruce on Q2 2020 Results - Earnings Call Transcript

IRIDEX Corporation (IRIX) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Hunter Cabi – Investor Relations Dave Bruce – Chief Executive Officer Jim MacKaness – Interim Chief Financial Officer Conference Call Participants Tom Stephan – Stifel Scott Henry – ROTH Capital Presentation Operator Ladies and...

SA Transcripts on Seeking Alpha | August 8, 2020

Iridex Corporation: Deserves More Patience Given Shift In Commercial Strategy And Aggressive Cost Cutting

It has been almost two years since our original article on IRIDEX Corporation (IRIX) was published. With the stock down almost 70% since that time, our long position has clearly not worked out. In retrospect, the title choice was very poorly chosen. It's a good time to revisit the investment...

Elle Investments on Seeking Alpha | August 7, 2020

IRIDEX Announces Second Quarter 2020 Financial Results

MOUNTAIN VIEW, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended…

GlobeNewswire | August 6, 2020

Analysts Estimate Iridex (IRIX) to Report a Decline in Earnings: What to Look Out for

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Read More 'IRIX' Stories Here

IRIX Price Returns

1-mo -5.06%
3-mo -18.36%
6-mo -34.50%
1-year -22.83%
3-year -80.57%
5-year -82.02%
YTD -24.22%
2019 -52.55%
2018 -38.32%
2017 -45.80%
2016 51.35%
2015 8.02%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8686 seconds.